Tangeretin Alleviates L-NAME Induced Vascular Dysfunction in Rats

Main Article Content

Chutamas Wunpathe
Putcharawipa Maneesai
Sarawoot Bunbupha
Thewarid Berkban
Parichat Prachaney
Upa Kukongviriyapan
Poungrat Pakdeechote

Abstract

Background and Objective: Tangeretin is a flavonoid compound found in citrus fruits.  Several biological activities of tangeretin have been revealed including; anti-neurodegeneration, anti-inflammation, and anti-oxidation. This study was to investigate the effects of tangeretin on vascular function in L-NAME-treated rats. 


Methods: Rats were divided into 4 groups. Groups I; rats treated with L-NAME (40 mg/kg) in drinking water only, Groups II and III; rats treated with L-NAME together with tangeretin (15 and 30 mg/kg, respectively), Groups IV;  control rats were received only distilled water (n=7/each group). At the end of experiment, vascular responses to electrical field stimulation (EFS) and vasoactive agents in mesenteric vascular beds and aortic rings were evaluated.


Results: A significant increase in contractile response to electrical EFS was observed in the mesenteric vascular bed isolated from L-NAME-treated rats (p<0.05).  Tangeretin reduced the augmented response to EFS in L-NAME-treated rats comparing to those of untreated rats (p<0.05).  However, the contractile response to exogenous norepinephrine was not different among groups.  Vasorelaxation responses to acetylcholine (ACh) in the mesenteric vascular beds and aortic rings were significantly blunted in L-NAME-treated rats compared to control rats (p<0.05).  Treatment with tangeretin improved the vasorelaxation response to ACh in L-NAME-treated rats compared to untreated rats (p<0.05).  There was no significant difference in the


vasorelaxation responses to sodium nitroprusside among groups.


Conclusions: The results of this study indicated that tangeretin suppresses sympathetic nerve mediated contractile response and improves endothelium-dependent vasorelaxtion in L-NAME-treated rats.  

Downloads

Download data is not yet available.

Article Details

Section
Original Articles

References

1. Bruno RM, Ghiadoni L, Seravalle G, Dell'Oro R, Taddei S, Grassi G. Sympathetic regulation of vascular function in health and disease. Front Physiol 2012; 3: 284
2. Wyss JM. The role of the sympathetic nervous system in hypertension. Curr Opin Nephrol Hy 1993; 2: 265-73
3. Bergamaschi CsT, Campos RR, Lopes OU. Rostral ventrolateral medulla: A source of sympathetic activation in rats subjected to long-term treatment with l-name. Hypertension 1999; 34: 744-7
4. Augustyniak RA, Victor RG, Morgan DA, Zhang W. L-name-and adma-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp 2006; 290: R726-32
5. Colonna VDG, Rossoni G, Rigamonti AE, Bonomo S, Manfredi B, Berti F, et al. Enalapril and quinapril improve endothelial vasodilator function and aortic enos gene expression in l-name-treated rats. Eur J Pharmacol 2002; 450: 61-6
6. Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, et al. Regression of l-name–induced hypertension: The role of nitric oxide and endothelium-derived constricting factor. Hypertens Res 2008; 31: 793
7. Fu J-Y, Qian L-B, Zhu L-G, Liang H-T, Tan Y-N, Lu H-T, et al. Betulinic acid ameliorates endothelium-dependent relaxation in l-name-induced hypertensive rats by reducing oxidative stress. Eur J Pharm Sci 2011; 44: 385-91
8. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type ii model of genetic diabetes. Eur J Pharmacol 2005; 511: 53-64
9. Lee YY, Lee E-J, Park J-S, Jang S-E, Kim D-H, Kim H-S. Anti-inflammatory and antioxidant mechanism of tangeretin in activated microglia. J Neuroimmune Pharmacol 2016; 11: 294-305
10. Yang J-s, Wu X-h, Yu H-g, Teng L-s. Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (mptp)-induced parkinson’s disease dementia in rats. Inflammopharmacology 2017; 25: 471-84
11. Lu H, Tan Y, Yang L, Dong H, Liao Y, Cao S, et al. Cardioprotective efficiency of tangeretin against heart failure induced by isoproterenol in rats. Int J Pharmacol 2018; 14: 1145-52
12. Omar HA, Mohamed WR, Arab HH, Arafa E-SA. Tangeretin alleviates cisplatin-induced acute hepatic injury in rats: Targeting mapks and apoptosis. PloS One 2016; 11: e0151649
13. Wu J, Zhao Y-M, Deng Z-K. Tangeretin ameliorates renal failure via regulating oxidative stress, nf-κb–tnf-α/inos signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats. Inflammopharmacology 2018; 26: 119-32
14. Kawasaki H, Takasaki K, Saito A, Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 1988; 335: 164-7.
15. Tousoulis D, Kampoli AM, Tentolouris Nikolaos Papageorgiou C, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012; 10: 4-18.
16. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflug Arch Eur J Phy 2010; 459: 923-39